The Expert Angle

Medlior is a well-known and trusted industry leader.

Our team is dedicated to delivering high-quality research that provides a solid basis for informed decision-making.

Medlior’s Expert Angle offers the inside track on new studies, industry hot topics, and what you need to know in the fast-paced world of clinical research, all from the point of view of the Medlior team of experts. From the latest topics and trends to the foundations of health and medical research, Medlior explores topics relevant to clients and the world.

Canada’s Rare Disease Strategy – What is it and why do we care?

Canada’s Rare Disease Strategy – What is it and why do we care?

Approximately 1 in 12 Canadians, mostly children, are affected by a rare disorder. Patients with rare diseases face many challenges, including misdiagnosis, limited treatment, and difficulty accessing innovative therapies even when they are available. Implementing the Rare Disease Strategy will not necessarily cost Canadians more. Earlier diagnosis and correct treatments can lead to reduced unnecessary surgeries, organ transplants, and visits to multiple specialists, resulting in savings for the health system and taxpayers.
Value-based Health Care 

Value-based Health Care 

Reflecting over the last 2 years The pandemic has shown us the crucial imperative of having highly functioning and interconnected healthcare systems. Everything comes at a cost which is why it is so important to achieve the greatest value for money. But what is value and whose values matter ...
Looking Forward To 2022 

Looking Forward To 2022 

Following the unprecedented year of 2020, 2021 brought increased global awareness to our field of work. The pandemic has brought terms such as ‘epidemiology’, ‘efficacy’ and ‘real word evidence’ into lay language and the vital role of health outcomes research has become increasingly apparent. ...
Looking Back On 2021

Looking Back On 2021

As the reality of living amongst a global pandemic set in across the world over the past year, a key highlight of 2021 was undoubtedly the rollout of life saving vaccines from AstraZeneca, Pfizer, Johnson and Johnson, and Moderna. At Medlior, this was also a year of continued ...
Trends in major adverse cardiac events during the COVID-19 pandemic in Alberta, Canada

Trends in major adverse cardiac events during the COVID-19 pandemic in Alberta, Canada

Dr. Shaun Goodman, from the Division of Cardiology, St. Michael's Hospital, Toronto, Ontario, and Canadian VIGOUR Centre, University of Alberta, Edmonton, Alberta, presented a poster at the 2021 Scientific Sessions American Heart Association Virtual Conference focusing on trends in major ...
Disease Burden of Huntington’s Disease in a Canadian Setting Using Administrative Health Data

Disease Burden of Huntington’s Disease in a Canadian Setting Using Administrative Health Data

A real-world evidence study focusing on the burden of Huntington’s disease (HD) in Alberta, was presented at the virtual 28thAnnual Meeting of the Huntington Study Group (HSG) from November 4-6, 2021. This study was conducted by Medlior on behalf of Hoffmann-La Roche. A background on ...
Virtual Canadian Congress of Cardiology Presentation: COVID-19 Pandemic Induced Disruptions in Troponin and Low-Density Lipoprotein Cholesterol Laboratory Test Volumes Across Alberta

Virtual Canadian Congress of Cardiology Presentation: COVID-19 Pandemic Induced Disruptions in Troponin and Low-Density Lipoprotein Cholesterol Laboratory Test Volumes Across Alberta

On March 11, 2020, the World Health Organization made the announcement that the coronavirus-2019 (COVID-19) was officially characterized as a pandemic.1 As many healthcare resources were redeployed or redistributed to address the acute need of COVID-19, large impacts on health systems were ...
Virtual ISPOR 2021: Burden of Disease and Current Treatment Patterns for Migraine in Canada

Virtual ISPOR 2021: Burden of Disease and Current Treatment Patterns for Migraine in Canada

E-Poster Title: Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada Migraine is a common, debilitating headache disorder that is the third leading cause of global disability and the leading cause of years lived with disability (YLDs) ...
COVID Vaccines in Canada

COVID Vaccines in Canada

COVID-19 has changed the entire world. In Medlior’s latest blog post, we look at vaccine development and approval in Canada, answering questions about how the vaccines could be developed so quickly, and what contributed to Canada’s slow start in rolling them out. Looking back, we can ...
Key Highlights From ISPOR 2021

Key Highlights From ISPOR 2021

The ISPOR 2021 annual conference was held last week. As usual, there were numerous insightful and thought-provoking sessions and workshops to attend, aimed at improving health economics and outcomes research (HEOR) research methods. Unsurprisingly, the COVID-19 pandemic was a common theme ...
Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada: A Literature Review

Epidemiology, Treatment Landscape, and Healthcare Resource Utilization for Patients with Migraine in Canada: A Literature Review

Synthetic Data and Real-World Evidence Studies

Synthetic Data and Real-World Evidence Studies

What is Synthetic Data? Synthetic data is the generation of realistic datasets that capture important relationships and information from real-world data. These datasets are created through random sampling models, such as Bayesian or neural networks, with the help of domain experts to validate ...